Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1613.65
-25.65 (-1.56%)
< Home < Back

USFDA conducting inspection at Sun Pharma’s Halol facility: Report

Date: 27-08-2018

The US Food and Drug Administration (USFDA) is reportedly conducting an inspection at Sun Pharmaceutical Industries’ Halol facility in Gujarat. The site produces multiple dosage forms from tablets to ointments to injectable and was cleared by the US drug regulator in June.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.